Paxlovid Is Associated With Lower Rates of Long COVID‐19 Smell and Taste Disorders
Early intervention with Paxlovid may decrease the risk of long COVID-19 smell/taste changes. Further study with a randomized controlled trial would help providers know more definitively if they should consider this utility in preventing long-term smell and taste loss.
Authors
- Esther Wang
- Zara M. Patel (ORCID: https://orcid.org/0000-0003-2072-982X)
Institutions
- University of Southern California (US)
- Stanford University (US)
Publication Details
- Journal
- International Forum of Allergy & Rhinology
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1002/alr.23612
- Citations
- 2
- Primary Topic
- Olfactory and Sensory Function Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.93